TP53-aberrated CLL: is BTK inhibitor monotherapy enough?

Adgang til dokumentet

@article{63238b434a504516bbbaa6825c67d21c,

title = "TP53-aberrated CLL: is BTK inhibitor monotherapy enough?",

author = "Niemann, \{Carsten Utoft\}",

year = "2026",

month = feb,

day = "10",

doi = "10.1182/bloodadvances.2025017954",

language = "English",

volume = "10",

pages = "707--709",

journal = "Blood advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "3",

}

TY - JOUR

T1 - TP53-aberrated CLL

T2 - is BTK inhibitor monotherapy enough?

AU - Niemann, Carsten Utoft

PY - 2026/2/10

Y1 - 2026/2/10

UR - https://www.scopus.com/pages/publications/105028535110

U2 - 10.1182/bloodadvances.2025017954

DO - 10.1182/bloodadvances.2025017954

M3 - Comment/debate

C2 - 41615766

AN - SCOPUS:105028535110

SN - 2473-9529

VL - 10

SP - 707

EP - 709

JO - Blood advances

JF - Blood advances

IS - 3

ER -